Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial

Siddharth Pravin Agrawal, Anjaneyulu Dunde, Pankti Maniyar, Jaisingh Rajput, Maharshi Raval, Darshil Maheta, Hritvik Jain, William H. Frishman, Wilbert S. Aronow

Open source

DOI
10.1097/crd.0000000000001220
Published
2026-03-20
Container
Cardiology in Review
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/crd.0000000000001220,
  title = {Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial},
  author = {Siddharth Pravin Agrawal and Anjaneyulu Dunde and Pankti Maniyar and Jaisingh Rajput and Maharshi Raval and Darshil Maheta and Hritvik Jain and William H. Frishman and Wilbert S. Aronow},
  year = {2026},
  journal = {Cardiology in Review},
  doi = {10.1097/crd.0000000000001220},
  url = {https://doi.org/10.1097/crd.0000000000001220}
}

RIS

TY  - JOUR
TI  - Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial
AU  - Siddharth Pravin Agrawal
AU  - Anjaneyulu Dunde
AU  - Pankti Maniyar
AU  - Jaisingh Rajput
AU  - Maharshi Raval
AU  - Darshil Maheta
AU  - Hritvik Jain
AU  - William H. Frishman
AU  - Wilbert S. Aronow
PY  - 2026
JO  - Cardiology in Review
DO  - 10.1097/crd.0000000000001220
UR  - https://doi.org/10.1097/crd.0000000000001220
ER  - 

APA

Agrawal, S. P., Dunde, A., Maniyar, P., Rajput, J., Raval, M., Maheta, D., Jain, H., Frishman, W. H., & Aronow, W. S. (2026). Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial. Cardiology in Review. https://doi.org/10.1097/crd.0000000000001220

Source records